Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Newton

Showing results (121-130 of 249) with videos related to

Pageof 25
Sort By:
JAMA|July 2, 2009
Novel and conventional biomarkers for prediction of incident cardiovascular events in the communityOlle Melander, Christopher Newton-Cheh, Peter Almgren, et al.
The New England Journal of Medicine|December 22, 2006
Multiple biomarkers for the prediction of first major cardiovascular events and deathThomas J Wang, Philimon Gona, Martin G Larson, et al.
Circulation|June 20, 2007
Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam StudyAlbert-Jan L H J Aarnoudse, Christopher Newton-Cheh, Paul I W de Bakker, et al.
The American Journal of Cardiology|April 27, 2022
Sex-Specific Differences in Ventricular Remodeling and Response After Cardiac Resynchronization TherapyDimitrios Varrias, Miguel Armengol De La Hoz, Megan Zhao, et al.
Journal of Molecular and Cellular Cardiology|November 30, 2016
The genetic component of bicuspid aortic valve and aortic dilation. An exome-wide association studyMarina Gago-Díaz, María Brion, Pastora Gallego, et al.
Annals of Medicine|January 23, 2009
High prevalence of four long QT syndrome founder mutations in the Finnish populationAnnukka Marjamaa, Veikko Salomaa, Christopher Newton-Cheh, et al.
Pharmacogenetics and Genomics|February 28, 2009
Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongationCharlotte van Noord, Albert-Jan L H J Aarnoudse, Mark Eijgelsheim, et al.
Journal of Clinical Psychopharmacology|January 15, 2009
Psychotropic drugs associated with corrected QT interval prolongationCharlotte van Noord, Sabine M J M Straus, Miriam C J M Sturkenboom, et al.
Journal of Molecular and Cellular Cardiology|February 1, 2011
Association of genetic variation in the natriuretic peptide system with cardiovascular outcomesKatrina L Ellis, Christopher Newton-Cheh, Thomas J Wang, et al.
Journal of the American College of Cardiology|July 30, 2011
Influence of sex and hormone status on circulating natriuretic peptidesCarolyn S P Lam, Susan Cheng, Karen Choong, et al.
Pageof 25

Showing results (121-130 of 249) with videos related to

Sort By:
Pageof 25
JAMA|July 2, 2009
Novel and conventional biomarkers for prediction of incident cardiovascular events in the communityOlle Melander, Christopher Newton-Cheh, Peter Almgren, et al.
The New England Journal of Medicine|December 22, 2006
Multiple biomarkers for the prediction of first major cardiovascular events and deathThomas J Wang, Philimon Gona, Martin G Larson, et al.
Circulation|June 20, 2007
Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam StudyAlbert-Jan L H J Aarnoudse, Christopher Newton-Cheh, Paul I W de Bakker, et al.
The American Journal of Cardiology|April 27, 2022
Sex-Specific Differences in Ventricular Remodeling and Response After Cardiac Resynchronization TherapyDimitrios Varrias, Miguel Armengol De La Hoz, Megan Zhao, et al.
Journal of Molecular and Cellular Cardiology|November 30, 2016
The genetic component of bicuspid aortic valve and aortic dilation. An exome-wide association studyMarina Gago-Díaz, María Brion, Pastora Gallego, et al.
Annals of Medicine|January 23, 2009
High prevalence of four long QT syndrome founder mutations in the Finnish populationAnnukka Marjamaa, Veikko Salomaa, Christopher Newton-Cheh, et al.
Pharmacogenetics and Genomics|February 28, 2009
Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongationCharlotte van Noord, Albert-Jan L H J Aarnoudse, Mark Eijgelsheim, et al.
Journal of Clinical Psychopharmacology|January 15, 2009
Psychotropic drugs associated with corrected QT interval prolongationCharlotte van Noord, Sabine M J M Straus, Miriam C J M Sturkenboom, et al.
Journal of Molecular and Cellular Cardiology|February 1, 2011
Association of genetic variation in the natriuretic peptide system with cardiovascular outcomesKatrina L Ellis, Christopher Newton-Cheh, Thomas J Wang, et al.
Journal of the American College of Cardiology|July 30, 2011
Influence of sex and hormone status on circulating natriuretic peptidesCarolyn S P Lam, Susan Cheng, Karen Choong, et al.
Pageof 25